enVVeno Medical (NVNO) Operating Leases (2019 - 2026)

enVVeno Medical's Operating Leases history runs 8 years deep, the most recent figure standing at $207000.0 for Q1 2026.

• On a quarterly basis, Operating Leases fell 66.01% year-over-year to $207000.0 in Q1 2026; TTM through Mar 2026 was $207000.0, a 66.01% decrease from a year earlier, with the FY2025 full-year figure at $310000.0, down 55.71% from the prior year.
• Operating Leases slipped to $207000.0 in Q1 2026 per NVNO's latest filing, from $310000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $1.6 million in Q1 2022 and bottomed at $207000.0 in Q1 2026.
• The 5-year median for Operating Leases is $973000.0 (2024), against an average of $958588.2.
• Across the five-year window, Operating Leases jumped 345.69% in 2022 and tumbled 66.01% in 2026, its largest moves.
• Year by year, Operating Leases stood at $1.4 million in 2022, then fell by 24.11% to $1.1 million in 2023, then sank by 34.21% to $700000.0 in 2024, then tumbled by 55.71% to $310000.0 in 2025, then slumped by 33.23% to $207000.0 in 2026.
• Per Business Quant, the three latest NVNO Operating Leases figures stand at $207000.0 (Q1 2026), $310000.0 (Q4 2025), and $505000.0 (Q3 2025).